These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3543527)

  • 1. Immunotoxin therapy of malignant melanoma.
    Spitler LE
    Med Oncol Tumor Pharmacother; 1986; 3(3-4):147-52. PubMed ID: 3543527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.
    Zovickian J; Johnson VG; Youle RJ
    J Neurosurg; 1987 Jun; 66(6):850-61. PubMed ID: 3033171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin.
    Spitler LE; del Rio M; Khentigan A; Wedel NI; Brophy NA; Miller LL; Harkonen WS; Rosendorf LL; Lee HM; Mischak RP
    Cancer Res; 1987 Mar; 47(6):1717-23. PubMed ID: 3493066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of metastatic malignant melanoma using Xomazyme Mel, a murine monoclonal anti-melanoma ricin A chain immunotoxin.
    Spitler LE; Mischak R; Scannon P
    Int J Rad Appl Instrum B; 1989; 16(6):625-7. PubMed ID: 2606718
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoclonal antibody immunoconjugates in the diagnosis and treatment of advanced melanoma.
    Bhardwaj S
    Mt Sinai J Med; 1992 May; 59(3):207-10. PubMed ID: 1603109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotoxin therapy of lymphoma.
    Grossbard ML; Nadler LM
    Cancer Treat Res; 1993; 68():111-31. PubMed ID: 8105846
    [No Abstract]   [Full Text] [Related]  

  • 7. Active specific immunotherapy with antiidiotypic antibodies in patients with solid tumors.
    O'Connell MJ; Chen ZJ; Yang H; Yamada M; Massaro M; Mittelman A; Ferrone S
    Semin Surg Oncol; 1989; 5(6):441-7. PubMed ID: 2688034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects for immunotoxin therapy of non-Hodgkin's lymphoma.
    Grossbard ML; Fidias P
    Clin Immunol Immunopathol; 1995 Aug; 76(2):107-14. PubMed ID: 7614729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic use of immunotoxins.
    Cobb PW; LeMaistre CF
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):6-13. PubMed ID: 1509295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies: potential applications to the treatment of cancer.
    Houghton AN; Scheinberg DA
    Semin Oncol; 1986 Jun; 13(2):165-79. PubMed ID: 3520825
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.
    Byers VS; Rodvien R; Grant K; Durrant LG; Hudson KH; Baldwin RW; Scannon PJ
    Cancer Res; 1989 Nov; 49(21):6153-60. PubMed ID: 2790828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotoxin therapy of leptomeningeal neoplasia.
    Walbridge S; Rybak SM
    J Neurooncol; 1994; 20(1):59-65. PubMed ID: 7807185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of antibodies or their fragments for the treatment of tumors].
    Douillard JY; Chatal JF
    Bull Cancer; 1998 Nov; 85(11):951-9. PubMed ID: 9951422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of human acute T-cell leukemia in SCID mice using the anti-CD7-deglycosylated ricin A-chain immunotoxin DA7.
    Jansen B; Vallera DA; Jaszcz WB; Nguyen D; Kersey JH
    Cancer Res; 1992 Mar; 52(5):1314-21. PubMed ID: 1371092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of ricin A-chain immunotoxins in leukemia and lymphoma.
    Engert A; Sausville EA; Vitetta E
    Curr Top Microbiol Immunol; 1998; 234():13-33. PubMed ID: 9670610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human antibody responses to components of the monoclonal antimelanoma antibody ricin A chain immunotoxin XomaZyme-MEL.
    Mischak RP; Foxall C; Rosendorf LL; Knebel K; Scannon PJ; Spitler LE
    Mol Biother; 1990 Jun; 2(2):104-9. PubMed ID: 2363853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for clinical use of immunotoxins in cancer and autoimmune disease.
    Byers VS; Baldwin RW
    Semin Cell Biol; 1991 Feb; 2(1):59-70. PubMed ID: 1954344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotherapy of cancer.
    Harris DT; Mastrangelo MJ
    Semin Oncol; 1989 Jun; 16(3):180-98. PubMed ID: 2658082
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.